Mperia Therapeutics Inc logo

Mperia Therapeutics Inc

Mperia Therapeutics, focusing on macrophage-targeting immunotherapy via CD36 scavenger receptor.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.mperiathera.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
1 Westmount Square, Suite 800 Quebec H3Z 2P9
Montreal-Ouest
Canada
Email
Contact Number
+ 1 647 291 8545

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/mperia-therapeutics-inc” connections=”true” suffix=””]